Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
10/04/2012 | US20120252860 Novel N, N'-Hydrazino-bis-isatin Derivatives with Selective Activity Against Multidrug-Resistant Cancer Cells |
10/04/2012 | US20120252818 Heat shock protein binding compounds, compositions, and methods for making and using same |
10/04/2012 | US20120252807 Arbovirus inhibitors and uses thereof |
10/04/2012 | US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase |
10/04/2012 | US20120252789 Inhibitors of sphingosine kinase |
10/04/2012 | US20120252788 5ht2c receptor modulators |
10/04/2012 | US20120252770 Chemical Compounds 572 |
10/04/2012 | US20120252740 Hdac inhibitors and therapeutic methods of using same |
10/04/2012 | US20120252699 Coupled recognition/detection system for in vivo and in vitro use |
10/04/2012 | US20120251579 Compositions for generating an antigen specific immune response |
10/04/2012 | US20120251551 Substituted (Heteroarylmethyl)thiohydantoins |
10/04/2012 | US20120251491 Fused tricyclic aryl compounds useful for the treatment of viral diseases |
10/04/2012 | US20120248973 Anthracene derivative and light-emitting device |
10/04/2012 | CA2831710A1 Substituted benzimidazoles as mps-1 kinase inhibitors |
10/04/2012 | CA2831590A1 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases |
10/04/2012 | CA2831582A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles , pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases |
10/04/2012 | CA2830650A1 Penoxsulam as an herbicide in alfalfa |
10/04/2012 | CA2830447A1 New azaspirodecanone compounds as hsl inhibitors |
10/03/2012 | EP2505586A1 Indole compound and pharmaceutical use thereof |
10/03/2012 | EP2504331A1 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
10/03/2012 | EP2504328A1 Novel compounds as receptor modulators with therapeutic utility |
10/03/2012 | EP2504314A1 Quinazoline derivatives |
10/03/2012 | CN102712647A Antimicrobial compounds and methods of making and using the same |
10/03/2012 | CN102712628A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
10/03/2012 | CN102712627A Process for preparation of pyrimidinylpyrazole compounds |
10/03/2012 | CN102712624A Indole compound and pharmaceutical use thereof |
10/03/2012 | CN102712623A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
10/03/2012 | CN102712621A Pyrazine derivatives and their use in the treatment of neurological disorders |
10/03/2012 | CN102712618A Novel compounds as receptor modulators with therapeutic utility |
10/03/2012 | CN102712606A Process for production of biphenyl derivative |
10/03/2012 | CN102712601A A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
10/03/2012 | CN102712600A Methods for the preparation of indazole-3-carboxyclic acid and n-(s)-1-azabicyclo[2.2.2]oct-3-yl-1h-indazole-3-carboxamide hydrochloride salt |
10/03/2012 | CN102702177A Method for preparing 1-substituted phenyl-4-ethoxycarbonyl-5-prolyl-1,2,3-triazole |
10/03/2012 | CN102702176A Preparation method for triphenyl candesartan |
10/03/2012 | CN102702175A Preparation method of indole-3-succinimide |
10/03/2012 | CN102702073A Oxime ester photoinitiators |
10/03/2012 | CN102702068A 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative, and application of 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative |
10/03/2012 | CN102696622A Pesticide composition capable of preventing and controlling plant disease |
10/03/2012 | CN101903341B Substituted N-phenyl-bipyrrolidine ureas and therapeutic use thereof |
10/03/2012 | CN101687801B Ethers of naphtalene carboxylic acid amides as cancer cure |
10/03/2012 | CN101389624B 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof |
10/03/2012 | CN101153036B Organic light-emitting compound and organic light-emitting element comprising the same |
10/02/2012 | US8278446 reacting 4-amino-6-chloro-pyrimidine-5-carbaldehyde with 4-benzyloxy-3-chloro-phenylamine in an aqueous solvent and a catalytic amount of hydrochloric acid, to providw 4-amino-6-(4-benzyloxy-3-chloro-phenylamino)-pyrimidine-5-carbaldehyde, then oximination with (2-morpholin-4-yl-ethyl)-hydroxylamine |
10/02/2012 | US8278442 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders |
10/02/2012 | US8278345 Inhibitors of glutaminyl cyclase |
10/02/2012 | US8278334 Cyclic amine BACE-1 inhibitors having a benzamide substituent |
10/02/2012 | US8278325 Nitrogen-containing heteroaryl compounds and methods of use thereof |
10/02/2012 | US8278307 Monocyclic Heteroaryl compounds |
10/02/2012 | US8277957 Quinoxaline derivatives and organic light-emitting diodes comprising the same |
10/02/2012 | CA2690953C Benzimidazole derivatives |
10/02/2012 | CA2575720C Pyrimidine derivatives |
10/02/2012 | CA2557115C Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
10/02/2012 | CA2556390C 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
10/02/2012 | CA2546300C 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
10/02/2012 | CA2535536C Substituted 3-pyrrolidine-indole derivatives |
10/02/2012 | CA2529453C Pyrrolidin-1,2-dicarboxylic acid-1-[(4-ethinyl-phenyl)-amide]-2-[(phenyl)-amide] derivative as inhibitors of coagulation factors xa and viia for the treatment of thromboses |
10/02/2012 | CA2520115C 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
10/02/2012 | CA2511613C Phosphonooxy quinazoline derivatives and their pharmaceutical use |
09/27/2012 | WO2012127032A1 Novel pyrimidine derivatives |
09/27/2012 | WO2012127030A1 Arylpiperazines as neuroprotective agents |
09/27/2012 | WO2012126922A1 Heterocyclic amine derivatives |
09/27/2012 | WO2011135520A8 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders |
09/27/2012 | US20120245352 Quinoxaline Compounds and Derivatives |
09/27/2012 | US20120245191 New azaspirodecanone compounds |
09/27/2012 | US20120245189 Crystalline cdc7 inhibitor salts |
09/27/2012 | US20120245182 Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1--1-methyl-urea and salts thereof |
09/27/2012 | US20120245176 Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals |
09/27/2012 | US20120245172 Heterocyclic amine derivatives |
09/27/2012 | US20120245148 Tetrahydroquinoxaline uera derivatives, their preparation and their therapeutic application |
09/27/2012 | US20120245143 3-0x0-2,3-dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition |
09/27/2012 | US20120245142 3-oxo-2,3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors |
09/27/2012 | US20120245138 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides |
09/27/2012 | US20120245125 Pyridazine compounds, compositions and methods |
09/27/2012 | US20120244079 Traceable retinoid acid for imaging, disease prevention and therapy |
09/27/2012 | US20120242936 Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Device Using the Quinoxaline Derivative |
09/27/2012 | CA2830129A1 Novel pyrimidine derivatives |
09/27/2012 | CA2828283A1 Heterocyclic amine derivatives |
09/26/2012 | EP2502924A1 Novel pyrimidine derivatives |
09/26/2012 | EP2502919A1 Process for production of biphenyl derivative |
09/26/2012 | EP2502918A1 Pyridizinone Derivatives |
09/26/2012 | EP2501695A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
09/26/2012 | EP2501694A1 Process for the preparation of crystalline form ii of l-malic acid salt of sunitinib |
09/26/2012 | EP2501691A1 Substituted pyrrolidine-2-carboxamides |
09/26/2012 | EP2501685A1 [1,5]-diazocin derivatives |
09/26/2012 | CN1938294B Novel pyrrolidine-3,4-dicarboxamide derivatives |
09/26/2012 | CN102695704A Indole derivatives and methods for antiviral treatment |
09/26/2012 | CN102695700A Pyrimidine derivatives as protein tyrosine kinase 2 inhibitors |
09/26/2012 | CN102695546A Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
09/26/2012 | CN102690238A Synthesis of barbituric acid derivative as RSK2 inhibitor and application thereof |
09/26/2012 | CN102690235A Iridium complex containing hole transporting functional group, and electroluminescent device of iridium complex |
09/26/2012 | CN102688234A Synthesis of indolone derivative as RSK2 inhibitor and application |
09/26/2012 | CN101611015B Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
09/26/2012 | CN101583365B Triazine derivatives and their therapeutical applications |
09/25/2012 | US8273895 NK1 antagonists |
09/25/2012 | US8273880 Pyrazole compounds with inhibitory activity against ROS kinase |
09/25/2012 | US8273878 Process for the preparation of pyrimidine compounds |
09/25/2012 | US8273782 Inhibitors of Akt activity |
09/25/2012 | US8273767 Bicyclic-substituted amines as histamine-3 receptor ligands |
09/25/2012 | US8273760 Indolo[3,2-c]quinoline compounds |
09/25/2012 | US8273734 5HT2C receptor modulators |